Rheumatoid Arthritis Drugs Market to Observe Strong Development of 10.5% CAGR by 2023 | Global Key Manufacturers - AbbVie, Amgen, Bayer, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, F. Hoffmann-La Roche

Marketprognosis.com Publish a New Market Research Report On “Global Rheumatoid Arthritis Drugs Market 2018 - 2023” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Rheumatoid Arthritis Drugs Market:

The Global Rheumatoid Arthritis Drugs Market is expected to register a CAGR of 10.5% during the forecast period of 2018-2023.

Rheumatoid Arthritis (RA) is an auto-immune disease that can cause joint pain and damage all over the body. As per the estimates of the World Health Organization (WHO), the prevalence varies between 0.3% and 1%, and it is more common in women and developed countries. Factors, such as the influx of new biopharmaceuticals, growing patient awareness of RA, and increasing prevalence of arthritis are expected to fuel the market’s growth, over the forecast period. Owing to the rise in the adoption of sedentary lifestyle, the patient pool in Asia-Pacific is expected to witness healthy growth. Therefore, Asia-Pacific is expected to emerge as the fastest growing segment of the market studied.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/17133 .

The major risk factors associated with the onset of rheumatoid arthritis are - genetics, environmental factors, hormones, and sedentary lifestyles. According to the estimates of the Centre for Disease Control and Prevention, during 2013-2015, an estimated 54.4 million US adults (about 22.7%) annually, were diagnosed with some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.

The alternative treatment options, such as acupuncture, physical therapy, and occupational therapy are expected to hamper the market’s growth. Most of the patients prefer medications related to rheumatoid arthritis. However, medications are not quite effective against RA. Therefore, most of the patients suffering from RA are opting for the above-mentioned alternative therapies.

North America dominates the global rheumatoid arthritis drugs market. The dominance of the region can be attributed to factors, such as ease of access to healthcare facilities, favorable reimbursement policies, robust clinical pipeline, and speedy approval of novel drugs. In addition, owing to increasing adoption of sedentary lifestyle, growing geriatric population, and immunological disorders, the region is experiencing a rise in the prevalence of rheumatoid arthritis. According to estimates of the Centre for Disease Control and Prevention (CDC) by 2040, about 78 million (26%) US adults aged 18 years or older are projected to have doctor-diagnosed arthritis. Hence, the aforementioned factors are expected to drive the growth of the North American segment of the market studied, over the forecast period.

Purchase this report online with 108 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/17133 .

Major Key Players:

1 AbbVie Inc.

2 Amgen Inc.

3 Bayer AG

4 Boehringer Ingelheim GmbH

5 Bristol-Myers Squibb Company

6 Celgene Corporation

7 F. Hoffmann-La Roche AG

8 Johnson & Johnson Services Inc. and More…………..

Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/17133 .

This study answers to the below key questions:

1 What will the market size be in 2023 and what will the growth rate be?

2 What are the key market trends?

3 What are the challenges to market growth?

4 Who are the key players in this market?

5 What are the market opportunities and threats faced by the key players?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Rheumatoid Arthritis Drugs Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.
Thane – 421501
India.

sales@marketprognosis.com
+1 973 241 5193
https://www.marketprognosis.com

This release was published on openPR.